Tag: Acquisition
Drug Research
Amgen Eyeing Preclinical Blood Cancer Program to Its Skills
Amgen is going ahead and adding Dark Blue to its tapestry, embedding the preclinical blood cancer program of U.K. biotech into its organization.
The California pharma has...
Business & Industry
J&J Acquires Clinical-Stage Biotechnology Firm for $3.05bn
Johnson & Johnson - J&J has completed the acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash.
This...
News
Celltrion Eyes Full-Scale Contract Manufacturing Operations
Celltrion on January 02, 2026, announced that it has completed the transfer of the biopharmaceutical production facility of Eli Lilly that’s located in Branchburg,...
Business & Industry
Sanofi to Buy Vaccine Developer Dynavax in a $2.5b Deal
The French pharma giant, Sanofi, has started a $15.50 per share cash tender offer when it comes to Emeryville, California-based vaccine developer Dynavax, which...
Business & Industry
Samsung Biologics to Buy US Drug Plant from GSK for $280M
On December 22, 2025, the news has been confirmed of Samsung Biologics to Buy US Drug Plant which is going to be its first...
Business & Industry
Sobi to Get Rights to Pozdeutinurad – Oral URAT1 Inhibitor
For a $950 million upfront, Sobi is all set to get rights to pozdeutinurad - oral URAT1 inhibitor that performed pretty well in the...
Business & Industry
Pfizer to Acquire Metsera in a $10bn Deal as Board Backs
The news of Pfizer to acquire Metsera in a $10bn deal has indeed caught the eye of many. Metsera happens to be a US-based...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read